Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 4:53 PM UTC
| NCT Number | NCT05256225 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE3 |
| Target Enrollment | 360 participants |
| Active Locations | 404 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 20, 2026 (Yesterday) |
As of July 21, 2026: Clinical trial NCT05256225 is currently recruiting participants. This phase3 study for endometrial cancer is actively seeking new participants at 404 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05256225 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 404 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05256225 was last updated Yesterday (July 20, 2026). HelloStudys verifies this status automatically.